Login or Sign Up
15:56 Apr 29
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:56 Apr 29
Quality
75/100
High Financial Strength
Valuation
15/100
Expensive Valuation
Technical
32/100
Technically Bearish
Strength
8
Weakness
6
Opportunity
1
Threats
0
0.56 %
Dividend Yield
16.30K
Market Cap (Cr)
37.65
RSI
44.08 %
Promoter Holding
30.29 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 21-Jun-2024 | Dividend | 8.75/share@875.00% | 22-Jun-2024 | 875.00 | Final |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
